NCT03395808View on ClinicalTrials.gov

Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

December 22, 2017

Primary Completion Date

April 25, 2019

Study Completion Date

May 6, 2019

Conditions
Pain Management
Interventions
DRUG

Tramadol

IV; 50 mg given at Hours 0, 2, 4, 8 and every 4 hours thereafter, for a total of up to 43 doses

Trial Locations (1)

91105

Lotus Clinical Research, Pasadena

Sponsors
All Listed Sponsors
lead

Avenue Therapeutics, Inc.

INDUSTRY

NCT03395808 - Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery | Biotech Hunter | Biotech Hunter